DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN TYPE 2 DIABETES. International Research Journal of Pharmacy, [S. l.], v. 2, n. 11, p. 125–126, 2011. Disponível em: https://irjponline.org/index.php/irjp/article/view/2988. Acesso em: 25 jul. 2026.